Medicine
Infant Dextrose 2500 mg/10 mL injection
Infant Dextrose 2500 mg/10 mL injection is a prescription medicine containing Dextrose for intravenous use, marketed by Henry Schein, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F) Product repackaged by: Henry Schein…
Key facts
- Active ingredient (INN)
- Dextrose
- Brand
- Infant Dextrose
- Strength
- 2500 mg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 syringe of 10 mL
- Marketing authorisation holder
- Henry Schein
- Manufacturer
- Henry Schein
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F) Product repackaged by: Henry Schein, Inc., Bastian, VA 24314 From Original Manufacturer/Distributor's NDC and Unit of Sale To Henry Schein Repackaged Product NDC and Unit of Sale Total Strength/Total Volume (Concentration) per unit NDC 0409-1775-10 Bundle of 10 Ansyr™ Plastic Syringes Single-dose containers NDC 0404-9844-10 1 10 mL Single-dose syringe in a bag…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B05CX01 Dextrose
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 January 2022
- Identifiers
- RxCUI 727518DailyMed set ID ce71d929-d11e-444c-bd45-e025d5172057NDC 0404-9844Application NDA019445
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe in 1 bag / 10 mL in 1 syringe | 0404-9844-10 | Henry Schein | 10 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 January 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dextrose 2500 mg/10 mL injection.
Other strengths and forms of Dextrose
Clinical summary
Dextrose is a prescription medicine indicated as source of water and calories in adult and pediatric patients, and may also be used as a diluent for reconstitution of a powder or liquid drug product. MedsAcross supplies Dextrose for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DextroseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DEXTROSE prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Infant Dextrose 2500 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.